A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients

NCT02453685 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

335

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart 30
DRUG: insulin glargine
DRUG: insulin aspart

Sponsor

Novo Nordisk A/S